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BST-2 restricts MMTV replication, but once infection has established, MMTV modulates BST-2 levels.
MMTV-directed BST-2 modulation is tissue-speciﬁc and dependent on infection and neoplastic
transformation status of cells. In the lymphoid compartment of infected mice, BST-2 expression is ﬁrst
upregulated and then signiﬁcantly downregulated regardless of absence or presence of mammary
tumors. However, in mammary gland tissues, upregulation of BST-2 expression is dependent on the
presence of mammary tumors and tumor tissues themselves have high BST-2 levels. Elevated BST-2
expression in these tissues is not attributable to IFN since levels of IFNα and IFNγ negatively correlate
with BST-2. Importantly, soluble factors released by tumor cells suppress IFNα and IFNγ but induce BST-2.
These data suggest that overexpression of BST-2 in carcinoma tissues could not be attributed to IFNs but
to a yet to be determined factor that upregulates BST-2 once oncogenesis is initiated.
& 2013 Elsevier B.V. All rights reserved.Introduction
Breast cancer is one of the leading causes of cancer associated
deaths in women. Breast cancer related deaths are in part due to
complications associated with metastasis that develops in regional
lymph nodes and in distant organs, including bone, lung, liver, and
brain (Fisher et al., 1983). The study of breast cancer biology and
pathogenesis has greatly beneﬁted from the use of mouse models
with the inherent advantage of controlled experimentation. One of
the leading breast cancer models is the mouse mammary tumor
virus (MMTV) long terminal repeat (LTR)-driven models that
permit controlled neoplastic transformation of mammary glandsll rights reserved.
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nes),
ahauad-Fernandez),and eventual development of mammary cancer through targeted
expression of various oncogenes or by infection with MMTV. MMTV
is an endemic betaretrovirus that causes mammary carcinomas upon
activation (Callahan and Smith, 2000; Nusse, 1991). Several mouse
strains carry MMTV and transmit the virus via the germline or
through the milk of infected females. MMTV initially infects antigen
presenting cells (APCs), including dendritic cells and B cells followed
by T cells (Courreges et al., 2007; Ross, 2010). MMTV-mediated
neoplastic transformation of mammary glands and development of
mammary cancer follows after APCs and T cells have been infected
by MMTV and trafﬁcked to mammary gland, infecting mammary
epithelial cells (Ross, 2010). Induction of mammary tumors by MMTV
is mediated by proviral integration into the host mammary epithelial
cells and activation of protooncogenes, such as Wnt genes, Fgf family
genes, Notch family genes, IntH/Int5, Int6, and Int41 (Callahan and
Smith, 2000; Durgam and Tekmal, 1994; Garcia et al., 1986; Gray
et al., 1986; Marchetti et al., 1995), and about 33 common insertion
sites recently identiﬁed in a high-throughput MMTV insertional
mutagenesis screen (Szabo et al., 2005).
Integration of MMTV into the host genome could result in over-
expression of natural cellular proteins or genes that are otherwise
tightly regulated. Like other cancers, breast cancer results from
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genes. One of the genes whose expression accelerates mammary
tumourigenesis induced by MMTV is Akt/PKB (Young et al., 2008). Akt
is a multifaceted Serine/Threonin protein kinase involved in inhibition
of apoptosis and the stimulation of cellular growth. There are 3 iso-
forms of Akt—named Akt1, Akt2, and Akt3 that are similar in their
activation/phorsphorylation (Datta et al., 1999). Expression of different
isoforms of Akt has been demonstrated in different human cancers,
such as Akt1 expression in gastric andmammary cancers (Young et al.,
2008, Maroulakou et al., 2007, Ju et al., 2007, Staal et al., 1977), Akt2
expression in ovarian and pancreatic cancers (Cheng et al., 1996,
Bellacosa et al., 1995), and Akt3 in mammary and prostate cancer cell
lines (Nakatani et al., 1999). The activation of Akt depends on
activation of its upstream kinases, including Phosphatidylinositol
3-kinase (PI3K) (Datta et al., 1999). PI3K play important role in
mediating cellular responses to extracellular signals (including cell
survival, growth and migration) and are implicated in the progression
of inﬂammatory diseases and cancer (Fougerat et al., 2009 and Denley
et al., 2008). There are three distinct sub-groups of PI3Ks, namely, class
I (A and B), class II, and class III; and the classiﬁcation is based on their
substrate speciﬁcity and sequence homology (Vanhaesebroeck et al.,
2001). The class I PI3Ks consist of four catalytic isoforms, p110α, p110β
and p110δ (class IA), and p110γ (class IB); each of which is bound to a
regulatory subunit (p85α, p85β, p55γ, p55α, p50α for class IA; p101 or
p84 for class IB) (Stephens et al., 1997, Krugmann et al., 1999, Suire
et al., 2005, Voigt et al., 2006). The different PI3K isoforms interact
with distinct subsets of downstream effectors thus allowing isoform
speciﬁc roles, including enhancement of transcription of a diverse
group of genes (Talapatra et al., 2001).
It has been shown that human cells expressing MMTV sequences
have enhanced transcriptional proﬁle of proinﬂammatory genes, such
as tumor necrosis factor (TNF), transforming growth factor beta (TGF-
β), and interferon-related genes with increased potential for cell
growth (Fernandez-Cobo et al., 2006). Indeed, the transmembrane
interferon-inducible gene called bone marrow stromal antigen 2 (BST-
2) or tetherin and known for blocking the release of nascent enve-
loped viruses from the surface of infected cells (Chu et al., 2012; Dafa-
Berger et al., 2012; Hammonds et al., 2012; Jones et al., 2013, 2012a;
Kong et al., 2012; Laplana et al., 2013; Mangeat et al., 2012; Pillai et al.,
2012), and inhibiting the replication of some retroviruses (Barrett
et al., 2012; Jones et al., 2012a; Liberatore and Bieniasz, 2011) is
overexpressed in different cancers. High levels of BST-2 were reported
in multiple myelomas (Hundemer et al., 2006; Walter-Yohrling et al.,
2003), metastatic ovarian cancers (Walter-Yohrling et al., 2003),
neoplastic B cells (Goto et al., 1994), metastatic mammary cancers
(Cai et al., 2009), and other cancer cells (Wainwright et al., 2011;
Walter-Yohrling et al., 2003). Although these studies showed that BST-
2 is overexpressed in cancer cells, there is no report on the progressive
changes in BST-2 levels that occur in different tissues of an intact host
during carcinogenesis. Here, we used C3H/HeN mouse strain to
describe tissue-speciﬁc differences in the expression patterns of BST-
2 in uninfected mice compared to mice suffering from MMTV
infection and MMTV-induced carcinogenesis.Results
Intrinsic expression of BST-2 in host cells potently impairs virus
replication
Previously, we utilized BST-2 targeting siRNA to locally suppress
BST-2 expression in murine lymph nodes and showed that down-
regulation of BST-2 results in higher MMTV replication (Jones et al.,
2012a). Since siRNA-dependent gene suppression is transient, we now
use mice with different copies of the BST-2 gene (Fig. 1A) including
homozygote WT (BST-2+/+; two copies of BST-2), homozygoteknockout (BST-2−/−; no copy of BST-2), and the heterozygote (BST-2
+/−; one copy of BST-2) to probe the role of BST-2 in MMTV
replication. Phenotypic examination of BST-2 transcript in naïve mice
shows that, as expected, BST-2−/− mice have no BST-2 mRNA in the
lymph node and spleen (Fig. 1B). However, mice with one copy of the
BST-2 gene (BST-2+/−) express about half BST-2 mRNA compared to
the WT mice (Fig. 1B). Similarly, BST-2 surface protein was higher in
WT mice compared to their BST-2+/− counterpart (Fig. 1C). Since BST-
2 mRNA is not present in BST-2−/− mice, we did not examine the
surface protein. Ex vivo infection of lymphocytes and splenocytes
obtained from WT, BST-2+/−, and BST-2−/− mice show that BST-2−/−
mice have signiﬁcantly higher MMTV proviral sequences as detected
by real-time PCR ampliﬁcation of the viral genome (Fig. 1D). Sub-
cutaneous inoculation of MMTV into murine footpad tissues show
that in vivo, MMTV replicates much better in BST-2−/−mice compared
to BST-2+/−, and WT in that order (Fig. 1E). The spread of infection
was also higher in BST-2−/− mice since more proviral sequence is
detected in the spleen of BST-2−/− mice than BST-2+/− and WT mice
(Fig. 1F). These data support our initial ﬁnding (Jones et al., 2012a) and
reveal that loss of BST-2 predisposes mice to signiﬁcant MMTV
replication. Because expression of BST-2 signiﬁcantly reduces viral
load, we examined the impact of acute MMTV infection on BST-2
expression. Thus, we queried the level of BST-2 surface protein and
mRNA in the lymph nodes and spleens of MMTV infected WT and
BST-2+/− mice using FACS and RT-qPCR, respectively. We observed a
substantial increase in BST-2 surface protein (Fig. 1G and H) andmRNA
(Fig. 1I and J) day 1 post infection. This increase was followed by a
signiﬁcant decrease 7 days later (Fig. 1G–J). To determine whether
higher viral products are released by infected BST-2−/− mice, we
quantiﬁed plasma viral loads by measuring the level of cell-free
plasma reverse transcriptase (RT) activity between WT, BST-2+/−,
and BST-2−/− mice day 1 and 7 after infection. Virion-associated RT
activity as determined by Molecular Probes EnzCheck Reverse Tran-
scriptase assay was signiﬁcantly higher in BST-2−/−mice compared to
BST-2+/−, and WT mice in that order (Fig.1K).Milk-borne infection of mice with MMTV results in changes in BST-2
expression
To further understand the effect of MMTV on BST-2 expression,
we examined the levels of BST-2 expression in mice infected via
the natural route. Spleens from age-matched pups nursed on C3H/
HeNdMMTV− (naïve) and C3H/HeNdMMTV+ (infected) mice were
examined for BST-2 expression using FACS analysis (Fig. 2A and B)
and RT-qPCR (Fig. 2C). We observed that in the naïve mice, level of
BST-2 protein and mRNA were lowest at day 3 and thereafter a
steady increase up to day 30 (Fig. 2A and C). In contrast, BST-2
surface protein and mRNA levels were highest in milk-borne
infected mice at day 3 with a signiﬁcant decline on days 7, 21,
and 30 (Fig. 2B and C). Examination of the proviral sequence by
PCR reveals that naïve mice lack MMTV sequence as expected
while infected mice harbor the proviral sequence (Fig. 2D). Of
note, levels of proviral DNA were lower on day 3 compared to
others days. This difference in the levels of proviral DNA could be
attributed to the age of the animals. Furthermore, since level of
BST-2 expression in MMTV infected mice decrease with age, we
examined the level of BST-2 in age-matched naïve and milk-borne
infected adult (5 weeks old) female mice. Results show that similar
to the weanlings, levels of BST-2 protein and mRNA in infected
mice are signiﬁcantly lower compared to the level in their naïve
counterparts (Fig. 2A–C). The suppression in BST-2 expression was
observed with respect to BST-2 transcript (Fig. 2E) and surface
protein (Fig. 2F) in peripheral blood mononuclear cells (PBMCs),
spleens, and lymph nodes. As expected, the infected mice harbor
MMTV proviral sequence in their chromosomes (Fig. 2G).
Fig. 1. Restriction of MMTV replication by BST-2 present in host target cells and modulation of BST-2 by MMTV. Homozygote WT and BST-2−/− mice were crossed to
generate the heterozygote BST-2+/− mice. The genotypes were conﬁrmed by PCR with primers that detect endogenous BST-2 and neomycin following previously described
protocol (Swiecki et al., 2012) (A). WT, BST-2+/− (+/−), and BST-2−/− (−/−) mice (n¼5/genotype) were phenotyped for BST-2 expression by RT-qPCR using BST-2 speciﬁc
primers (B) or by FACS - ﬂuorescence activated cell sorting (C). Lymphocytes and splenocytes obtained from WT, BST-2+/− (+/−), and BST-2−/− (−/−) mice were infected ex
vivowith MMTV. DNA isolated from cells was examined for level of infection by qPCR 24 h later (D). Naïve age-matched WT, BST+/−, and BST-2−/−mice (n¼5/genotype/time
point) were infected with MMTV by subcutaneous injection on the hind footpad. On days 1 and 7, groups of 5 mice/genotype were sacriﬁced. Single cells from the lymph
nodes and spleens were used for qPCR ((E) and (F)), FACS ((G) and (H)), and RT-qPCR ((I) and (J)) to determine the level of virus replication, surface level of BST-2, and BST-2
transcripts, respectively. (K) RT-based plasma viral loads as determined by Molecular Probes EnzCheck Reverse Transcriptase Assay was performed with cell-free plasma
fromWT, BST-2+/−, and BST-2−/−mice (n¼5) infected with MMTV for 1 and 7 days. RT activity of the samples was extrapolated from the RT standard curve and presented as
fold change of RT units in 1 ml of WT plasma. PCR data are normalized to GAPDH and presented as fold change relative to proviral DNA (VDNA) or BST-2 mRNA in WT mice.
Error bars are standard deviation; ** is signiﬁcance with p value less than 0.01 and * is signiﬁcance with p value less than 0.05. The numbers next to histogram legend denote
mean ﬂorescence intensity (MFI) of surface BST-2 levels. Experiments were performed with 5 mice per genotype and repeated at least 3 times with similar results.
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changes in BST-2 and viral nucleic acids expression in the lymphoid
compartment
The major pathology observed in MMTV infected mice is mam-
mary cancer. Different inbred strains of mice have different inci-
dences and types of cancers. Some strains such as C57BL/6 are
resistant to MMTV-induced mammary cancer while others such as
C3H and BALB/c are very susceptible to mammary cancer develop-
ment. The C3H strain has a high incidence (470%) of mammary
cancer development in both virgin and breeding mice, while C57BL/6has a very low incidence (o5%). Given the high propensity of
MMTV-induced mammary cancer in C3H/HeN and the fact that no
signiﬁcant difference exist in BST-2 mRNA expression between
C57BL/6 and C3H/HeN mice (Jones et al., 2012a), we used C3H/
HeNdMMTV+ non-tumor bearing (infected) and C3H/HeNdMMTV+
tumor-bearing (tumor-bearing) mice to further dissect the effect of
MMTV on BST-2 expression in mice infected with MMTV and
suffering from mammary cancer. Comparison of BST-2 expression
levels in the lymphoid compartments (PBMCs, spleen, and lymph
node) that are targets of MMTV infection using RT-qPCR and FACS
show levels of BST-2 mRNA (Fig. 3A) and protein (Fig. 3B) to be
Fig. 2. MMTV acquired via the natural route regulates BST-2 expression. Age-matched C3H/HeNdMMTV− and C3H/HeNdMMTV+mice (n¼3) were bred. Their pups (n¼5/time
point) were sacriﬁced at different time points (3, 7, 21, and 30 days) as shown on the ﬁgures. At necropsy, splenocytes were subjected to FACS analysis of BST-2 surface protein
((A) and (B)), RT-qPCR of BST-2 mRNA expression (C), and PCR of MMTV proviral DNA levels (D). PBMCs were obtained from adult (5 weeks old) C3H/HeNdMMTV− (naïve) and
C3H/HeNdMMTV+ (infected) mice (n¼3) prior to sacriﬁce. At necropsy, spleens and lymph nodes, as well as the isolated PBMCs were subjected to RT-qPCR examination of BST-
2 levels following RNA isolation and cDNA synthesis (E), FACS analysis of surface BST-2 (F). DNA isolated from the cells was used for PCR examination of proviral DNA (G). RT-PCR
data are normalized to GAPDH and presented as relative levels (C) or as fold change relative to BST-2 mRNA in naïve mice (E). GAPDH was also used as loading control ((D) and
(G)). Error bars are standard deviation; ** is signiﬁcance with p value less than 0.01 and * is signiﬁcance with p value less than 0.05. The numbers next to histogram legend
denote mean ﬂorescence intensity (MFI) of surface BST-2 levels. Experiments were repeated at least three times with similar results.
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bearing mice. Levels of cell associated proviral DNA (VDNA) and viral
RNA (VRNA) were higher in these tissues (Fig. 3C and D). The thymus,
another target of MMTV, had signiﬁcantly lower BST-2 in non-tumor
bearing mice as shown for other lymphoid organs (Fig. 3E). However,
the thymi of tumor-bearing mice have 5 times more BST-2 mRNA
compared to the levels in the naïve thymi (Fig. 3E) and the level of
cell associated VDNA (Fig. 3F) and VRNA (Fig. 3G) in the thymi of
tumor-bearing mice was also higher compared to that in non-tumor
bearing mice.
Changes in BST-2 and viral nucleic acid levels in non-lymphoid tissues
Although MMTV does not replicate well in non-lymphoid tissues,
expression of MMTV proviral DNA was demonstrated in C3Hf/HeSed
mouse liver, kidney, lung, and intestine (Chen et al., 1990). Moreover,
presence of MMTV-like envelope sequences has been shown in liver
biopsies of disease but not in normal human liver (Johal et al., 2009).
To determine the impact of MMTV on BST-2 levels in non-lymphoid
tissues, we used RT-qPCR to evaluate level of BST-2 mRNA and viral
nucleic acids in bone marrow cells, liver, lung, heart, and kidney. Ourdata show that as in the lymphoid tissues, BST-2 levels is signiﬁcantly
lower in bone marrow cells, lung, liver, and heart of MMTV infected
and tumor-bearing mice compared to the naïve mice (Fig. 4A–D). But
in the kidney, MMTV did not change the level of BST-2 in infected
mice and there was a slight but non-signiﬁcant increase in BST-2
mRNA in the kidney of tumor-bearing mice (Fig. 4E). In contrast to
level of BST-2, both viral RNA and proviral DNA expression are
signiﬁcantly higher in liver, lung, heart, and kidney, but not in bone
marrow cells of tumor-bearing mice compared to infected mice
(Fig. 4F–I). Although BST-2 expression is suppressed in lung, liver, and
heart of infected and tumor-bearing mice to similar levels, viral
nucleic acids level differed, with the tumor-bearing mice harboring
signiﬁcantly more viral products, especially notable in the heart
(Fig. 4H and I).
BST-2 is highly overexpressed in tumor tissues and mammary glands
of tumor-bearing mice
Since MMTV infects mammary gland cells resulting neoplastic
epithelial cell transformation, we examined the levels of BST-2 in
mammary gland tissues of naïve mice, non-tumor-bearing mice
Fig. 3. Differential BST-2 expression in murine lymphoid compartment during MMTV infection and carcinogenesis. C3H/HeNdMMTV+ mice infected via milk during nursing
were sacriﬁced after 2 pregnancies (n¼5, age¼5 months) or allowed to develop mammary tumor (n¼5, age¼5 to 7 months). Mice bearing tumor were sacriﬁced in accordance
to the policies of the University of Iowa Institutional Animal Care and Use Committee. Lymph nodes, PBMCs, and spleens as indicated in the ﬁgures were used for RNA and DNA
extraction. RNAwas used for determination of BST-2 mRNA by RT-qPCR (A). Single cells from these tissues were subjected to FACS analysis for BST-2 surface protein (B). DNA and
cDNA were used for qPCR detection of viral DNA (C) while cDNA was used for viral RNA detection (D). Thymi tissues obtained from naïve C3H/HeN mice and the C3H/
HeNdMMTV+ and their tumor-bearing counterparts described above were subjected to RT-qPCR to determine level of BST-2 transcripts and viral RNA ((E) and (G)). Thymic viral
DNA was quantiﬁed using isolated DNA (F). RT-PCR data are normalized to GAPDH and presented as fold change relative to BST-2 mRNA or viral RNA in infected or naïve mice
depending on experiment. Error bars are standard deviation; ** is signiﬁcance with p value less than 0.01 and * is signiﬁcance with p value less than 0.05. The numbers next to
the legend denote mean ﬂorescence intensity (MFI) of surface BST-2 levels. These experiments were repeated at least three times with similar results.
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signiﬁcant change occurred in BST-2 mRNA levels of naïve and
infected non tumor-bearing mice, expression of BST-2 transcript
was about 8 times higher in the mammary gland tissues of tumor
bearing mice (Fig. 5A). Comparison of BST-2 levels in mammary
gland and tumor tissues show that BST-2 level is signiﬁcantly
higher in tumor tissues compared to mammary gland tissues
obtained from the same tumor-bearing mice (Fig. 5B). We also
used FACS analysis to compare the levels of BST-2 surface protein
in lymphoid and tumor tissues from the same animal and show
that BST-2 surface protein is signiﬁcantly higher in tumor tissues
(Fig. 5C).
Increased BST-2 expression in mammary gland and mammary tumor
tissues from tumor-bearing mice correlates with high tissue and
plasma viral load
BST-2 functions to block the replication of MMTV following
experimental infection of mice (Fig. 1D–G). Moreover, lower levels
of BST-2 mRNA and surface protein observed in lymphoid and
non-lymphoid tissues of tumor-bearing mice (Fig. 3A, B andFig. 4B–D) inversely correlates with level of viral nucleic acids in
these lymphoid cells (Fig. 3C and D) with the thymi as an
exception (Fig. 3E–G). In the thymus, BST-2 mRNA was slightly
suppressed in MMTV infected mice but upregulated in the thymi
from tumor-bearing mice (Fig. 3E). Although BST-2 mRNA is
signiﬁcantly higher in the thymi of tumor-bearing mice compared
to their non-tumor bearing counterparts, both VDNA and VRNA
levels were also higher in the tumor-bearing mice (Fig. 3F and G),
suggesting that high level of BST-2 may be responsible for
accumulation of viral nucleic acids or that BST-2 is not restricting
virus replication in the thymi. To determine whether high BST-2
levels in mammary gland and tumor tissues correlate with viral
gene expression, we subjected DNA and RNA samples from these
tissues to qPCR and RT-qPCR, respectively. We show that in spite of
the high BST-2 mRNA in mammary glands from tumor-bearing
mice, these tissues contain signiﬁcantly more VDNA (Fig. 5D) and
VRNA (Fig. 5E) when compared to mammary glands from infected
non tumor-bearing mice. Comparison between mammary gland
and tumor tissues from the same tumor-bearing mice indicates
that tumor tissues harbor more viral DNA and RNA than mammary
gland tissues (Fig. 5F and G); again despite high BST-2 level
Fig. 4. MMTV modulates BST-2 levels in non-lymphoid tissues. C3H/HeNdMMTV+ mice infected via milk during nursing were sacriﬁced after 2 pregnancies (n¼5, age¼5
months) or allowed to develop mammary tumor (n¼5, age¼5 to 7 months). As stated above, mice bearing tumor were sacriﬁced in accordance to the policies of the
University of Iowa Institutional Animal Care and Use Committee. Following euthanasia, bone marrow cells, liver, lung, heart, and kidney were collected and used for DNA and
RNA extraction. Reverse transcribed RNA was used to quantify BST-2 mRNA levels ((A) to (E)) and viral RNA levels ((G) and (I)). DNA was used to quantify proviral DNA
expression ((F) and (H)). PCR data are normalized to GAPDH and presented as fold change relative to samples from the naïve and infected mice. Error bars are standard
deviation; ** is signiﬁcance with p value less than 0.01 and * is signiﬁcance with p value less than 0.05. Experiments were repeated several times with similar results.
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measured RT activity in cell-free plasma. Fig. 5I show that
tumor-bearing mice harbor about 14 times more cell-free virus
in their plasma compared to their non-tumor bearing counterparts
(Fig. 5I). Together, these data suggest that high levels of BST-2 in
mammary gland and tumor tissues do not impact cell associated
and cell-free viral load in mice suffering from MMTV-induced
mammary cancer.
BST-2 is overexpressed in mammary carcinoma epithelial cells
Although both mammary gland and mammary tumor tissues
consist of many different cell types, including ﬁbroblasts, adipocytes,
inﬂammatory cells and epithelial cells, mammary carcinomas are
epithelial neoplasms. Hence, we examined levels of BST-2 mRNA and
surface protein in normal murine mammary epithelial cells (NMuMG)
and mammary carcinoma cells (Mm5MT and 4T1). We observed that
both 4T1 and Mm5MT cells have comparable levels of BST-2 mRNA
(Fig. 6A) and surface protein (Fig. 6B). BST-2 levels in these carcinoma
cell lines are signiﬁcantly higher than that in normal mammary
epithelia (Fig. 6A and B). Since Mm5MT cells were derived from
mammary tumor of C3H/HeN mice, we wondered if BST-2 levels in
the tumor and tumor-derived epithelial cells will be comparable. RT-
qPCR analysis showed that although mammary carcinoma cells
express more BST-2 compared to normal mammary epithelia control,
FACS and RT-qPCR analysis reveal that signiﬁcant differences exist
among tumor tissues, mammary gland from tumor-bearing mice,
tumor-derived mammary gland cells, and normal mammary gland
cells (Fig. 6C). Compared to normal mammary epithelial cells, BST-2
levels are higher in mammary carcinoma epithelial cells, mammary
gland tissues, and tumor tissues in that order. To determine whether
higher BST-2 expression impacts viral load, we examined the level ofcell associated viral nucleic acids (DNA and RNA). We observed
signiﬁcantly higher viral gene expression in the form of integrated
provirus and viral RNA (Fig. 6D), as well as viral protein (Fig. 6E) in
mammary gland and tumor tissues in that order; compared to
Mm5MT cells.
High levels of BST-2 in tumor-derived mammary epithelial cells,
mammary gland, and mammary tumor tissues correlate with levels
of PI3K, MIP-1α/CCL3, and AKT mRNAs
Since Integration of MMTV into the host genome could change
expression patterns of multiple genes, we sought to identify other
genes whose expressions correlate with BST-2. High levels of
phosphoinositide 3 kinase (PI3K) have been reported in different
cancers (Fransson et al., 2013), making PI3K a good candidate gene.
Examination of PI3K expression show that the genes encoding the
different isoforms (PI3KCA, PI3KCB, PI3KCD, PI3KCG) of the cata-
lytic subunit of PI3K are highly elevated in mammary gland tissues
(Fig. 7A). PI3KCA was approximately 100 times and 250 times
higher in mammary gland tissues from infected and tumor-
bearing mice, respectively, compared to their naïve counterpart
(Fig. 7A). Comparison of mRNA levels of PI3K isoform subunits
between mammary gland and tumor tissues revealed a slight
increase in PI3KCA and PI3KCB in tumor tissues over mammary
gland (Fig. 7B). The high levels of the catalytic PI3K isoforms led us
to evaluate the level of the regulatory subunit of PI3K (encoded by
PIK3R1). Our analysis reveals that no differences exist in PI3KR1
levels in mammary gland and tumor tissues (Fig. 7C). Furthermore,
signiﬁcant induction of PI3KCA, PI3KCB, PI3KCD, and PI3KCG was
observed in Mm5MT cells over NMuMG cells (Fig. 7D). However,
PI3KR1 level was not signiﬁcantly different between Mm5MT and
NMuMG cells (Fig. 7E).
Fig. 5. Mammary gland and Tumor tissues from C3H/HeNdMMTV+ tumor-bearing mice show high levels of BST-2 and viral nucleic acids. C3H/HeNdMMTV+mice infected via
milk during nursing were sacriﬁced after 2 pregnancies (n¼5, age¼5 months) or allowed to develop mammary tumor (n¼5, age¼5 to 7 months). As stated above, mice bearing
tumor were sacriﬁced in accordance to the policies of the University of Iowa Institutional Animal Care and Use Committee. Mice were bled for PBMC isolation prior to
euthanasia. PBMCs, lymph nodes, spleens, tumor tissues, and mammary gland tissues devoid of lymph nodes were used for DNA and RNA extraction. RNA was reverse
transcribed to cDNA and used to quantify BST-2 mRNA levels ((A) and (B)). Single cells from the lymphoid and tumor tissues were subjected to FACS examination of BST-2
surface protein (C), while DNA was used to quantify proviral DNA ((D) and (F)); cDNA was quantiﬁed by RT-qPCR to determine levels of viral RNA expression ((E) and (G)).
Cell-free plasma collected from the above infected and tumor-bearing mice (n¼5) were used for examination of plasma viral load by vRNA (H) or RT activity (I). All PCR data are
normalized to GAPDH and presented as fold change relative to samples from the naïve and infected mice. RT activity was extrapolated from the RT standard curve and presented
as fold change of RT units in 1 ml of infected plasma. Error bars are standard deviation; ** is signiﬁcance with p value less than 0.01 and * is signiﬁcance with p value less than
0.05. The numbers next to histogram legend denote mean ﬂorescence intensity (MFI) of surface BST-2 levels. Experiments were repeated several times with similar results.
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been shown to inﬂuence MMTV-induce mammary tumorigenesis
(Young et al., 2008), we examined the level of AKT expression in
mammary gland and tumor tissues. Our data reveal that AKT1 and
AKT3 isoforms are elevated in infected mammary gland tissue but
AKT2 is downregulated (Fig. 8A). Similarly, levels of AKT1 and
AKT3 are also elevated in mammary gland of tumor-bearing
mice over tumor tissue and non-tumor bearing mammary gland
tissues in that order (Fig. 8B). Moreover, AKT1 and AKT3 but not
AKT2 are elevated in Mm5MT cells compared to NMuMG cells
(Fig. 8C). This result prompted us to examine the expression levels
of the two forms of phospho-Akt (pAktS473 and pAKTT308). Both
naïve and MMTV infected mammary gland tissues express
pAktS473 and pAKTT308 (Fig. 8D). Examination of pAkt levels in
infected non-tumor-bearing mammary gland, tumor-bearingmammary gland and tumor tissues show no change in pAkt
expression (Fig. 8E).
Given that the PI3K pathway is activated by macrophage
inﬂammatory protein 1-alpha (MIP1-α/CCL3) (Lentzsch et al.,
2003) and MIP1-α/CCL3 plays important role in amplifying inﬂam-
mation (Staudt et al., 2013), we examined the level of MIP1-α/CCL3
in mammary and tumor tissues. As was observed for BST-2 and
PI3K, MIP1-α/CCL3 mRNA level is highly elevated in mammary
gland and tumor tissues compared to naïve mammary gland
(Fig. 8F). Moreover, MIP1-α/CCL3 mRNA level in Mm5MT cells is
also elevated compared to the level in NMuMGs (Fig. 8G). These
data show positive correlative expression levels of BST-2, PI3K,
AKT, and MIP1-α/CCL3 in tumor-derived mammary epithelial cells,
mammary gland, and tumor tissues, and indicate that BST-2 is not
the only elevated gene during MMTV-induced carcinogenesis.
Fig. 6. Mammary carcinoma epithelial cells overexpress BST-2 and viral nuclei acids. Normal mammary epithelial cells (NMuMG) and carcinoma mammary epithelial cells
(4T1 and Mm5MT) were used for RNA extraction and RT-qPCR examination of BST-2 mRNA (A). A portion of cells were used for FACS analysis of BST-2 surface protein (B).
RNA isolated from mammary epithelial cells (NMuMG and Mm5MT), mammary gland from tumor-bearing mice (n¼5) and mammary tumor tissues from the same mice
were reverse transcribed and used to examine BST-2 transcripts by RT-qPCR (C). DNA, RNA, and protein isolated from cells and tissues as indicated in the ﬁgure were
examined for levels of proviral DNA and viral RNA (D) as well as viral protein (E). RT-qPCR and qPCR data are normalized to GAPDH and presented as fold change relative to
samples from NMuMG or Mm5MT. Viral protein was detected with MMTV capsid antibody (α- p27) and GAPDH was used as loading control. Error bars are standard
deviation; ** is signiﬁcance with p value less than 0.01 and * is signiﬁcance with p value less than 0.05. The numbers next to histogram legend denote mean ﬂorescence
intensity (MFI) of surface BST-2 levels. All experiments were repeated 3 times with similar results.
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It is well known that BST-2 expression is principally induced by
IFNs (Jones et al., 2013, 2012a; Yoo et al., 2011). To assess the level
of types I and II IFN during MMTV pathogenesis and to determine
whether levels of IFNs correlate with BST-2, we evaluated the
transcripts of IFNα and IFNγ in representative lymphoid, mam-
mary, and tumor tissues from naïve, infected, and tumor-bearing
mice. In the lymphoid compartment (lymph node and PBMC), IFNα
was repressed in both infected and tumor-bearing mice but IFNγ
was induced in infected mice (Fig. 9A and B). In contrast, both IFNα
and IFNγ mRNA were signiﬁcantly suppressed in the mammary
gland tissues of infected and tumor-bearing mice (Fig. 9C). There
was no signiﬁcant difference in levels of IFNα and IFNγ betweenmammary gland and tumor tissues, although level of IFNα was
slightly lower in tumor tissues (Fig. 9D). We also compared
expression levels of IFNα and IFNγ in normal and tumor-derived
mammary epithelial cells and showed that as with tissues from
tumor-bearing mice, tumor-derived mammary epithelial cells
have signiﬁcantly lower levels of both IFNα and IFNγ transcripts
compared to normal mammary epithelial cells (Fig. 9E). IFN
protein levels were not assessed since level of IFNα mRNA
was low in all tissues tested and there is no correlation between
BST-2 and IFNs mRNA. Our data indicate that mice suffering
from MMTV-induced mammary cancer have suppressed levels
of IFNα and IFNγ expression, suggesting that these IFNs may
not be responsible for inducing BST-2 in mammary gland and
tumor tissues.
Fig. 7. Expression levels of some PI3K isoforms in C3H/HeN mammary gland and tumor tissues positively correlate with BST-2. RNA isolated from mammary gland and
tumor tissues from Naïve mice (n¼5), infected mice (n¼5), and tumor-bearing mice (n¼5) described in Fig. 5, or mammary epithelial cells (NMuMG and Mm5MT) described
in Fig. 6 was used. Transcript levels of PI3KCA, PI3KCB, PI3KCD, and PI3KCG in mammary gland tissues (A) and mammary gland and tumor tissues (B) were compared by RT-
qPCR analysis. Level of PI3KR1 mRNA was compared between mammary gland tissues and tumor tissue (C). PI3KCA, PI3KCB, PI3KCD, PI3KCG, and PI3KR1 mRNAs in
mammary epithelial cells were analyzed by RT-qPCR (D and E). Graphs represent means and error bars are standard deviation; ** is signiﬁcance with p value less than 0.01
and * is signiﬁcance with p value less than 0.05. Experiments were repeated 3 separate times with similar results.
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and II IFNs and elevate BST-2 expression in normal mammary
epithelial cells ex vivo
Since BST-2 expression is enhanced but IFNα and IFNγ expression
are impaired in mammary and tumor tissues, we wanted to evaluate
the impact of soluble factors secreted by tumor cells on BST-2 and
IFNs expression. We used an in vitro culture model to mimic the
in vivo microenvironment by exposing normal mammary epithelial
cells (NMuMGs) to supernatants derived from single cell suspension
of primary tumor cells (tumor conditioned medium, TCM). We also
exposed normal mammary epithelial cells to supernatants derived
from single cell suspensions of splenocytes exposed to LPS (spleno-
cyte conditioned medium, SCM) for positive control. We observed
that while normal mammary epithelial BST-2 protein (Fig. 10A) and
mRNA (Fig. 10B) were highly induced by tumor-conditioned medium
(TCM), IFNα and IFNγ mRNA (Fig. 10C) were signiﬁcantly suppressed
by TCM. In contrast, SCM signiﬁcantly mediated the induction of
BST-2, IFNα, and IFNγ expression (Fig. 10A–C). These data suggest
that soluble factors secreted by tumor cells may be partly respon-
sible for inducing BST-2 expression in mammary epithelial cells.
Moreover, our data is in agreement with a published report which
showed that breast tumor environment blocks type IIFN production
(Sisirak et al., 2013). To identify the soluble factors present in TCM,
we used mouse inﬂammatory cytokines multi-analyte ELISArray Kit
to identify the cytokines secreted into culture medium. Results show
increased levels of interleukin 6 (IL6) and Granulocyte colony-
stimulating factor (G-CSF) in TCM compared to medium alone
(Fig. 10D). Studies are ongoing to determine whether these factors
are directly involved in mediating BST-2 induction.Discussion
Overexpression of BST-2 gene has been detected in various
human tumor cell lines and tissues (Cai et al., 2009; Hundemer
et al., 2006; Wainwright et al., 2011; Walter-Yohrling et al., 2003),
and an earlier study showed that neoplastic B cells have high level of
BST-2 (Goto et al., 1994). Here, we show that BST-2 is overexpressed
in mammary gland and tumor tissues from MMTV tumor-bearing
mice, as well as in mammary carcinoma cell lines isolated from
MMTV-induced mammary cancer. MMTV is a useful tool for identi-
fying genes that play a role in viral pathogenesis and human
mammary tumorigenesis. It has been suggested that the incidence
of human breast cancer correlates with risk factors such as age, diet,
obesity, family history (Kelsey, 1993; Szabo et al., 2005), and
distribution of MMTV in house mice (Stewart et al., 2000). Although
knowledge about the involvement of MMTV in human mammary
carcinogenesis is still evolving, MMTV is thought to be involved in
human mammary carcinogenesis due to the identiﬁcation of
sequences homologous to the env gene of MMTV in about 40% of
human breast cancers (Faedo et al., 2004; Ford et al., 2004; Langerod
et al., 2007; Wang et al., 2003). Hence, understanding the role of BST-
2 in MMTV infection and MMTV-induced mammary carcinogenesis
could improve our understanding of the biology and pathogenesis of
mammary cancer.
In this study, we used mice with different genetic makeup to
examine the effect of BST-2 expression in infection of MMTV target
tissues and analyzed the impact of MMTV infection on the expres-
sion levels of BST-2. We found that expression of BST-2 in target
tissues/cells blocks the replication of MMTV. Endogenous RT assay
revealed that viral load was signiﬁcantly higher in BST-2−/− mice
Fig. 8. AKT1, AKT3, and MIP1α/CCL3 mRNA correlate with BST-2 but AKT2 mRNA does not correlate with BST-2 in mammary gland and tumor tissues of C3H/HeN. Transcript
levels of AKT1, AKT2, and AKT3 in mammary gland, tumor tissues and mammary epithelial cells were determined by RT-qPCR analysis of cDNA obtained from total RNA of
naïve mice (n¼5), infected mice (n¼5), mice bearing mammary tumor (n¼5), NMuMG, and Mm5MT cells ((A) to (C)). AKT protein level was determined by Western blot
using total cell lysate probed with phospho-speciﬁc antibodies and total AKT antibody for loading control ((D) and (E)). Expression level of MIP1α/CCL3 in mammary gland,
tumor tissues and mammary epithelial cells were determined by RT-qPCR analysis of cDNA obtained from total RNA of naïve (n¼5), infected (n¼5), mice bearing mammary
tumor (n¼5), NMuMG, and Mm5MT cells ((F) and (G)). Graphs represent means and error bars are standard deviation; ** is signiﬁcance with p value less than 0.01 and * is
signiﬁcance with p value less than 0.05. Experiments were repeated 3 separate times with similar results.
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activity in BST-2−/− plasma may indicate that more virions are
released by infected BST-2−/−mice or it could be a marker of higher
viral load since it has been suggested that endogenous RT activity is
the best surrogate measure of infectious HIV-1 titer (Liu et al., 2010).
Although BST-2 inhibits MMTV replication, we found that MMTV
modulates BST-2 expression in a biphasic manner. MMTV ﬁrst
enhances BST-2 expression both during footpad inoculation and
gut infection via contaminated breast milk. The increase in BST-2
levels is followed by signiﬁcant down modulation days later. In the
lymphoid compartments which are targets of MMTV infection
(Ross, 2010), BST-2 expression was high 24 h after infection fol-
lowed by a signiﬁcant decline. This observation is partly in line with
an earlier demonstration that BST-2 expression is signiﬁcantly high
during acute HIV infection of PBMCs (Homann et al., 2011). Similar
to the observation in lymphoid tissues, BST-2 levels in non-
lymphoid tissues, including bone marrow, liver, lung, and heart,
but not kidney was suppressed by infection with MMTV. Indeed,
viruses such as HIV and chikungunya virus use different mechan-
isms, including removal of BST-2 from the cell membrane and BST-2
degradation to regulate BST-2 expression and neutralize its anti-
viral activity (Gofﬁnet et al., 2010; Jones et al., 2012a; Neil et al.,
2008; Perez-Caballero et al., 2009; Radoshitzky et al., 2010; Skasko
et al., 2012; Watanabe et al., 2011). It is therefore possible that
MMTV modulates BST-2 levels to allow its replication.Since MMTV is an oncoRNAvirus (Allred and Medina, 2008;
Callahan and Smith, 2008; Dickson et al., 1984; Kim et al., 2011;
Kuriki et al., 2000; Marcotte and Muller, 2008) and infection with
this virus results in oncogenic transformation of mammary gland
tissues and tumor induction, we hypothesized that modulation of
BST-2 in mammary gland tissues will depend on transformation
status of the mammary epithelia, with transformed epithelial cells
expressing lower levels of BST-2 similar to the lymphoid tissues.
Remarkably, we observed tissue speciﬁc differences in BST-2 expres-
sion in mice during the course of MMTV infection. Compared to
naïve mice, BST-2 levels in lymphoid, non-lymphoid, and mammary
tissue compartments in MMTV infected non-tumor bearing mice
was signiﬁcantly lower. Furthermore, in comparison to their infected
non tumor-bearing counterparts or uninfected (naïve) controls, mice
bearing mammary tumors have signiﬁcantly high BST-2 mRNA and
surface protein levels in the mammary gland and tumor tissues.
However, in their lymphoid and non-lymphoid tissues with the
exception of the thymus and kidney, BST-2 is signiﬁcantly repressed.
The observed tissue speciﬁcity in BST-2 expression prompted us to
examine the level of viral genetic materials in the respective tissues
to determine whether higher BST-2 expression will inversely corre-
late with viral loads, in agreement with the role of BST-2 in
restricting acute infection (Homann et al., 2011; Jones et al.,
2012a). Unexpectedly, BST-2 levels in the thymus, mammary gland
and tumor tissues positively correlate with proviral DNA and viral
Fig. 9. Levels of IFNα and IFNγ negatively correlate with BST-2 in tissues of mice bearing mammary tumor. Levels of IFNα and IFNγ in lymph node (A), PBMC (B), and
mammary gland tissues (C) were analyzed by RT-qPCR of cDNA obtained from total RNA of naïve mice (n¼5), infected mice (n¼5), and mice bearing mammary tumor (n¼5).
IFNα and IFNγ levels were compared between mammary gland and tumor tissues from the same mice (D), or between NMuMG and Mm5MT cells (E). Graphs represent
means and error bars are standard deviation; ** is signiﬁcance with p value less than 0.01 and * is signiﬁcance with p value less than 0.05. Experiments were repeated
3 separate times with similar results.
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correlation between BST-2 level and viral nucleic acids in liver, lung,
heart, and kidney of tumor-bearing mice. These observations partly
agrees and partly contradicts the anti-viral function of BST-2 as
clearly demonstrated in Fig. 1, which shows that loss of BST-2 gene
enhances cell-associated viral nucleic acids expression and cell-free
virion associated RT activity. It therefore seems that once infection
establishes and mammary cell transformation initiates, BST-2 may
lose its anti-viral potency or in addition to its anti-viral function,
may assume a role in tumorigenesis that is yet to be determined.
Because mammary carcinomas are epithelial neoplasms, we used
different mammary carcinoma epithelial cell lines to probe the
regulation of BST-2 by MMTV. Compared to normal mammary
epithelial cells, BST-2 mRNA and surface protein levels are signiﬁ-
cantly higher in the transformed epithelial cells although not to the
level observed in mammary gland and tumor tissues. The differences
in BST-2 expression may stem from the fact that the epithelial cells
are homogenous while mammary gland and mammary tumor
tissues consist of many different cell types such as macrophages
that may have different expression proﬁles than the epithelial cells.
Nonetheless, BST-2 expression is about 6 times higher in carcinoma
mammary epithelial cells than in normal mammary epithelia. Inter-
estingly, examination of known tumor stimulatory factors, including
PI3K, AKT, and MIP1α/CCL3 reveals elevated levels of all 3 genes in
carcinoma cells and tissues compared to normal cells/tissues. PI3K,
AKT, and MIP1α/CCL3 have been implicated in a variety of normal
and patho-physiological responses, involving regulation of immune
response and pathogenesis of different cancers, such as has been
reported for the involvement of Akt1 in murine mammary cancer
(Maroulakou et al., 2007; Young et al., 2008) and elevated levels of
MIP1α/CCL3 in human breast cancer (Burger et al., 2009), orpromotion of angiogenesis by MIP1α/CCL3 (Wu et al., 2008). The
ﬁnding that expression patterns of BST-2, PI3K, AKT, and MIP1α/CCL3
are altered in mammary tissues during MMTV infection and MMTV-
induced mammary carcinogenesis may imply that elevated BST-2
levels may be an epiphenomenon of proviral expression and tumor
growth. It could also be that BST-2 plays a critical role in mammary
tumorigenesis. Indeed, published reports have implicated BST-2 as a
tumor promoting gene as shown with the demonstration that the
application of anti-BST2 antibody to endometrial cancer cells
resulted in cytotoxic effect in BST2-positive cells (Yokoyama et al.,
2012). Similarly, anti-BST-2 antibody substantially reduced tumor
growth in mice (Schliemann et al., 2010). In contrast, there is evi-
dence that BST-2 could function as an inhibitor of cancer cell growth
and migration since BST-2 inhibits membrane type 1-matrix
metalloproteinase (MT1-MMP)-mediated cell growth and migration
(Gu et al., 2012).
Many factors have been implicated in upregulation of BST-2
expression, notably IFNα (Jones et al., 2013, 2012a), IFNγ (Yoo et al.,
2011), and even viral infections (Homann et al., 2011). However, we
found that chronic infection with MMTV suppresses both BST-2 and
IFNα and upon tumor development, both IFNα and IFNγ are sup-
pressed, while BST-2 is elevated. While changes in BST-2 during
mammary cancer has not been reported prior to our study, our data
on IFNα suppression is in agreement with published data which
demonstrated suppressed levels of type I IFNs (α/β) and TNFα (Sisirak
et al., 2013) in mammary cancer. Thus, induction of BST-2 in tumor-
derived mammary epithelial cells, mammary gland, and tumor
tissues could not be attributed to IFNα and IFNγ since very low
expression of these IFNs were observed in tissues from tumor
bearing mice. Although it is known that BST-2 is an IFNα-regulated
gene, it has been reported that engagement of Ig-like Transcript 7
Fig. 10. Tumor-conditioned medium mediates induction of BST-2 in mammary epithelial cells. Normal mammary epithelial cells (NMuMG) were cultured in normal medium
(Medium), tumor conditioned medium (TCM), and splenocyte conditioned medium (SCM). A portion of cells were used for FACS analysis of BST-2 surface expression levels
(A). The remaining portion of cells was used to determine level of BST-2 mRNA (B) and IFNα/IFNγ mRNA (C). Cell culture medium (Medium) and TCM devoid of particulate
materials were used in mouse inﬂammatory cytokines multi-analyte ELISA to determine cytokines and/or chemokines present in TCM (D). Graphs represent means and error
bars are standard deviation; ** is signiﬁcance with p value less than 0.01 and * is signiﬁcance with p value less than 0.05. The numbers next to histogram legend denote mean
ﬂorescence intensity (MFI) of surface BST-2 levels. Experiments were repeated 3 separate times with similar results.
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duction of IFNα (Cao et al., 2009). Therefore in tumor cells, it may be
possible that shut down of IFNα production is facilitated by BST-2.
However, this does not explain the low level of IFNα in tissues with
low BST-2 levels such as some lymphoid and non-lymphoid tissues.
In the absence of IFNs expression, increased BST-2 expression
observed in carcinoma tissues could be attributed to tumor cells
themselves, peritumoral cells present at the tumor site, or to
soluble factors released by tumor cells. In our studies, we found
that tumor conditioned medium (TCM) induced BST-2 surface
protein and mRNA but suppressed IFNα and IFNγ mRNA in normal
mammary epithelial cells. It is well known that cancer cell-derived
soluble factors mediate different biological activities (Guerrero
et al., 2010; Li and Galileo, 2010; Toulza et al., 2005) and that
soluble factors released by breast tumor block type I IFN produc-
tion (Sisirak et al., 2013). Our study identiﬁed IL6 and G-CSF as
soluble factors present in high levels in TCM. Although a recent
study found that IL6 does not induce BST2, it is noteworthy that
the referenced study was conducted on human monocytes and T
cells (Guzzo et al., 2012). That being said, we have not directly
tested whether recombinant IL6 or G-CSF could induce BST-2 in
mammary epithelial and/or tumor cells. It is however interestingthat we observed the presence of both IL6 and G-CSF in TCM
because previous work by others have shown that IL6 and G-CSF
are produced by tumor and/or stromal cells in malignant
tumors (Shojaei et al., 2007). IL6 and G-CSF in conjunction with
phospho-STAT3 have been implicated in the protumor function of
neutrophils (Yan et al., 2013). Furthermore, G-CSF is involved in
promoting tumor angiogenesis (Okazaki et al., 2006; Shojaei et al.,
2009) and increased levels of serum IL-6 have been associated
with poor prognosis in human mammary cancer (Zhang and
Adachi, 1999).
While the role of BST-2 in mammary tumorigenesis is yet to be
determined, we speculate that misregulated gene expression
commonly observed during mammary cell transformation and/or
soluble factors in tumor microenvironment may be at least partly
responsible for BST-2 upregulation. Upon induction, BST-2 may
serve as an adhesion molecule by preferentially recruiting various
cell types from blood to the site of inﬂammation and/or facilitating
tumor cell contact with the endothelium, thus, contributing to
cancer metastasis and progression. Consistent with this idea is the
ﬁnding that the monocytic cell line U937 adheres to BST-2
extracellular domain-coated tissue culture wells (Yoo et al.,
2011). Further studies are therefore required to identify other cel-
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tissues, as well as decipher the role of BST-2 in mammary carcino-
genesis.Experimental procedures
Ethics statement
All experiments involving mice were performed in accordance
to NIH guidelines, the Animal Welfare Act, and US federal law.
The experiments were approved by the University of Iowa Animal
Care and Use Committee (IACUC). Mice were housed according to
the policies of the Institutional Animal Care and Use Committee of
the University of Iowa.
Animals
BST-2−/− mice generated with 129/SvJ mice (Swiecki et al., 2012)
were kindly provided by Dr. Marco Colonna of Washington Uni-
versity, MO. BST-2−/− females were backcrossed to C57BL/6 males for
9 generations. WT and BST-2+/− mice were generated from crosses
between BST-2−/− and WT and PCR genotyped where applicable.
C3H/HeNdMMTV+ and C3H/HeNdMMTV−were purchased from the
National Cancer Institute (NCI). C3H/HeNdMMTV+ were bred for
2 pregnancies after which the males were removed to prevent future
pregnancy and slow time to tumor development or the mice were
force-bred until mammary tumor developed. Mice were sacriﬁced in
accordance to the policies of the University of Iowa Institutional
Animal Care and Use Committee.
Infection of mice
In vivo infection of mice was performed as previously described
(Jones et al., 2012b; Mehta et al., 2012; Okeoma et al., 2010, 2007,
2009a, 2009b, 2008). At different times after infection, mice were
sacriﬁced and relevant tissues were harvested. Tissues and/or single
cells derived from tissues were used for downstream analysis.
Cell lines
NMuMG (derived from normal mammary tissue of a Namru
mouse strain) and Mm5MT (a mouse mammary carcinoma cell line
from C3H/HeN mouse strain) were purchased from American Type
Culture Collection (ATCC). 4T1 (a mouse mammary carcinoma cell
line from Balb/c mouse strain) is a kind gift from Dr. Lyse Norian of
the University of Iowa. All cells were maintained according to the
suppliers' instructions.
Generation of primary tumor cells
Mammary tumors were aseptically excised from the mammary
fatpad of C3H/HeNdMMTV+ mice into PBS. Tumor explants were
washed with PBS ﬁrst and then homogenized in serum-free RPMI-
1640. Tumor homogenates were digested in RPMI-1640 containing
0.2% Collagenase A, 5% FBS, 0.2% Trypsin, and 5 ug/ml Gentamycin
at 37 1C for 30 min with shaking at 100 rpm. Tumor digest were
passed through a cell strainer and cells pelleted. Cells were cultured
in RPMI-1640 containing 10%FBS, and 1% penicillin/streptomycin.
Conditioned medium
Tumor cell conditioned medium (TCM) obtained from primary
tumor cells and splenocyte conditioned medium (SCM) obtained
from LPS-treated splenocytes were prepared as follows. Single
cells from tumor cells or splenocytes were plated in 3-wells of6-well plate. LPS at 1 mg/ml was added to the splenocyte culture
and allowed to incubate for 15 min. Splenocytes were washed and
resuspended in fresh medium. All cells were allowed to incubate
at 37 1C for 24 h. Prior to treatment of epithelial cells, conditioned
TCM and SCM were collected, centrifuged for 10 min at 2000 rpm
and then ﬁltered through a 0.22-μm ﬁlter (VWR). The media were
placed on ice and UV-treated for 1 h followed by ultracentrifuga-
tion for 3 h at 32000 rpm. Supernatants were used to treat cells.
Antibodies
Goat anti-p27 (capsid) has been previously described (Jones et al.,
2012a; Okeoma et al., 2007, 2008). Anti-pAKTS473, anti-pAKTT308, and
anti-AKT were purchased from Cell Signaling Technology. Alexa ﬂour
647 conjugated anti-mouse BST-2 clone 129c, and FITC conjugated
anti-mouse BST-2 clone 927 purchased from eBioscience. Goat anti-
GAPDH was from Santa Cruz Biotech and IRDye 800CW donkey anti-
goat was purchased from Li-core.
Western blots
Western blots were performed as previously described (Jones
et al., 2012b; Mehta et al., 2012; Okeoma et al., 2009a). Blots were
probed with anti-p27, anti-pAKTS473, anti-pAKTT308, anti-AKT, and
anti-GAPDH depending on experiment. The species-appropriate
IRDye secondary antibodies were used followed by detection with
the Odyssey Infrared Imaging System (LI-COR Biosciences).
ELISA
Cytokine/Chemokine Multi-Analyte ELISA Array (Qiagen, USA)
was performed according to manufacturer's instructions. Brieﬂy, cell
culture supernatant samples were centrifuged at 1000 g for 10 min
to remove particulate material. Assay buffer (50 ml) was added to
each well of the ELISA plate followed by 50 ml of sample or antigen
standard cocktail. The plate was then covered, gently swirled for 10 s
and incubated at room temperature for 2 h. The contents of the wells
were decanted and wells were washed three times with 350 ml of
wash buffer. Detection antibody diluted in assay buffer (100 ml) was
added to the wells, gently swirled and incubated for 1 h at room
temperature. The plate was washed three times. Avidin-HRP diluted
in assay buffer (100 ml) was added to the wells, gently swirled and
incubated in the dark for 30 min at room temperature. The plate was
washed four times. Development solution (100 ml) was added to the
wells and incubated in the dark for 15 min. Stop solution (100 ml)
was added to the wells and the absorbance was read at 450 nm using
a Tecan Inﬁnite M200 PRO plate reader (Tecan).
DNA, RNA isolation and real-time quantitative PCR (qPCR)
Isolation of DNA and RNA were accomplished using ZR-Duet
DNA/RNA MiniPrep (ZYMO Research) according to manufacturer's
instructions. For cDNA synthesis, equivalent amounts of RNA
treated with DNase I (Qiagen) were reverse-transcribed with high
capacity cDNA reverse transcription Kit (ABI), and the cDNA was
ampliﬁed with target speciﬁc primers. Semi-quantitative PCR was
performed using ABI Veriti 96-Well thermal cycler; quantitative
real time qPCR (qPCR) and reverse transcription real time qPCR
(RT-qPCR) were carried out using ABI 7500 FAST thermal cycler.
Sequences of primer pairs used are available upon request.
Flow cytometry
Approximately, 1106 Mm5MT, NMuMG, 4T1, and lympho-
cytes were stained in PBS with relevant antibodies as previously
described (Jones et al., 2012a; Okeoma et al., 2008). Following
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subjected to FACS. Using FACS calibur ﬂow cytometer (BD), at least
ten-thousand events were collected for each sample. FACS data
were analyzed by Flowjo software (TreeStar).
Reverse transcriptase assay
Reverse transcriptase activity was determined in cell-free plasma
according to the manufacturer's recommended protocol (Molecular
Probes EnzCheck Reverse Transcriptase Assay Kit). Brieﬂy, 5 ml of poly
(A) ribonucleotide template was added to 5 ml of oligo d (T) 16
primer and incubated at room temperature for 1 h. Template/primer
solution was diluted 200 fold in polymerization buffer and 20 ml
aliquots were added to wells of a black optical bottom plate
(Thermo Fisher). Samples and standards (GeneMate room tempera-
ture 200 U/ml) were diluted 2 fold in 50 mM Tris–HCl, 20% glycerol,
2 mM DTT, pH 7.6. 5 ml of samples or standards were added to the
reaction mixture in the wells of the black optical bottom plate and
incubated at room temperature for 1 h. The reaction was stopped
with 2 ml of 200 mM EDTA per sample/standard. 173 ml of PicoGreen
working solution diluted in TE buffer was added to the samples/
standards and incubated at room temperature for 5 min. Fluores-
cence (Ex: 480 nm, Em: 520 nm) was measured using a ﬂuorescent
plate reader (Tecan Inﬁnate M200 PRO, Tecan Austria/Europe).
Reverse transcriptase activity of the samples was calculated from
the reverse transcriptase standard curve.
Statistical analysis
Statistical analysis of signiﬁcant differences was tested using
paired two-tailed Student's t test. A p value of 0.05 was considered
signiﬁcant. Error bars represent standard deviations.Authors' contributions
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